`
`Paper No. __
`
`
`
`
`
`For the Petitioner
`Lead counsel: Robert W. Hahl, Reg. No. 33,893
`Backup counsel: Robert Mihail, Reg. No. 66,021
`Backup counsel: John K. Pike, Reg. No. 41,253
`Neifeld IP Law, PC
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`
`Coalition For Affordable Drugs V LLC
`Petitioner
`v.
`
`Biogen MA Inc.
`Patent Owner
`____________
`
`Case IPR2015-01993
`Patent 8,399,514
`Title: TREATMENT FOR MULTIPLE SCLEROSIS
`____________
`
`
`
`
`DECLARATION OF ROBERT MIHAIL
`
`
`Page 1 of 5
`
`
`
`1. I am an attorney employed by Neifeld IP Law, PC.
`
`2. On 9/19/2015 I accessed the URL https://clinicaltrials.gov/show/NCT00168701
`
`and saw that the top-level domain is a “dot-gov” domain.
`
`3. On 4/29/2015 I read that 41 CFR §102-173.30 states “Who may register in the
`
`dot-gov domain? Registration in the dot-gov domain is available to official
`
`governmental organizations in the United States including Federal, State, and local
`
`governments, and Native Sovereign Nations.”
`
`4. Based on the above findings, I concluded that the domain name clinicaltrials.gov
`
`of the URL https://clinicaltrials.gov/show/NCT00168701 is registered by an
`
`official governmental organization in the United States.
`
`5. On 9/19/2015 I downloaded the document contained at URL
`
`https://clinicaltrials.gov/show/NCT00168701, now marked as Ex. 1040.
`
`6. On 9/19/2015 I clicked the hyperlinked text “History of Changes” located on the
`
`first page of Ex. 1040. Upon clicking said hyperlink I was taken to URL
`
`https://clinicaltrials.gov/ct2/archive/NCT00168701. A copy of the webpage located
`
`at said URL is now marked as Ex. 1041.
`
`7. On 9/19/2015 I clicked the hyperlinked text “ClinicalTrials.gov Archive Site”
`
`located on the first page of Ex. 1041. Upon clicking said hyperlink I was taken to
`
`Page 2 of 5
`
`
`
`URL https://clinicaltrials.gov/archive/NCT00168701. A copy of the webpage
`
`located at said URL is now marked as Ex. 1042.
`
`8. On 9/19/2015 I clicked the hyperlinked text “Study” located immediately to the
`
`right of “2005-09-14” under the Column titled “Updated”. Upon clicking said
`
`hyperlink I was taken to URL
`
`https://clinicaltrials.gov/archive/NCT00168701/2005_09_14. A copy of the
`
`webpage located at said URL is now marked as Ex. 1022.
`
`9. On 9/19/2015 I accessed the URL https://www.clinicaltrials.gov/ct2/about-
`
`site/background and downloaded the webpage, now marked as Ex. 1043.
`
`10. On 9/19/2015 I read from the first page of Ex. 1043 that “The results database
`
`was made available to the public in September 2008. FDAAA 801 also established
`
`penalties for failing to register or submit the results of trials. See the History,
`
`Policies, and Laws page for more information about the development of
`
`ClinicalTrials.gov. Because ClinicalTrials.gov is a government Web site, it does
`
`not host or receive funding from advertising or the display of commercial content.”
`
`11. On 9/19/2015 I also read from the second page of Ex. 1043 that “[t]he full
`
`history of changes made to a record can be accessed by viewing the archival
`
`version of the record on the ClinicalTrials.gov archive. Once a study is registered
`
`on the site, the information about it is not removed.”
`
`Page 3 of 5
`
`
`
`Based on my observations of the information and documents contained in
`
`paragraphs 1-11 above, I concluded that (1) the webpage now marked as Ex. 1022
`
`is an archival page of the study marked as “NCT00168701,” that (2) the
`
`information on webpage now marked as Ex. 1022 was publicly available on
`
`09/14/2005 and (3) that information contained on the webpage now marked as Ex.
`
`1022 was not removed since 09/14/2005.
`
`
`
`In signing this declaration, I understand that the declaration will be filed as
`
`evidence in a contested case before the Patent Trial and Appeal Board of the
`
`United States Patent and Trademark Office. I acknowledge that I may be subject to
`
`cross examination in the case and that cross examination will take place within the
`
`United States. If cross examination is required of me, I will appear for cross
`
`examination within the United States during the time allotted for cross
`
`examination.
`
`
`
`I also swear under penalty of perjury of the laws of the United States that the
`
`foregoing is true and correct.
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted
`
`By: /RobertMihail/
`
`Robert Mihail (Reg. No. 66,021)
`Back-up Counsel for the Petitioner
`Date: 9/27/2015
`Neifeld IP Law, PC
`4813-B Eisenhower Avenue
`
`Page 4 of 5
`
`
`
`Alexandria, VA 22304
`Tel: 1-703-415-0012
`Email: rmihail@neifeld.com
`
`
`Page 5 of 5
`
`